Mobix Labs Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Rhea-AI Summary

Mobix Labs (Nasdaq: MOBX) received a 180-calendar-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

Key dates: Nasdaq first notified Mobix Labs of non-compliance on April 17, 2025; the company achieved ten consecutive days at or above $1.00 on September 11, 2025; Nasdaq advised on October 8, 2025 about extending the required consecutive-business-day test; the new deadline to regain compliance is April 27, 2026. Nasdaq's extension does not immediately affect listing status.

Positive

• 180-day extension granted to April 27, 2026
• No immediate effect on MOBX listing status
• Achieved 10 consecutive days at or above $1.00 on Sep 11, 2025

Negative

• Initial non-compliance notice issued on April 17, 2025
• Failure to comply by April 27, 2026 will trigger delisting notification
• Shares would not remain listed pending a Nasdaq Hearings Panel decision

IRVINE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. (Nasdaq: MOBX) ("Mobix Labs" or the "Company"), a fabless semiconductor company delivering advanced wireless and wired connectivity, RF, switching, and filtering technologies for next-generation communication systems, announced today that it has received an additional 180-calendar-day extension from the Nasdaq Stock Market ("Nasdaq") to regain compliance with the minimum bid price requirement, as outlined in Nasdaq Listing Rule 5550(a)(2).

The Company was first notified by Nasdaq that it was non-compliant with the minimum bid price requirement on April 17, 2025, and was given until October 14, 2025, to regain compliance. During the Initial Compliance Period, the Company’s Class A Common Stock (“Common Stock”) maintained closing bid prices at or above $1.00 for ten consecutive trading days, achieving that level on September 11, 2025. On October 8, 2025, Nasdaq subsequently advised the Company that it was exercising its discretion to extend the number of days that the Company must maintain a bid price of at least $1.00 for 20 consecutive business days.

The Company now has until April 27, 2026, to meet the requirement for its shares of Common Stock to maintain a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days.

Nasdaq's extension notice has no immediate effect on the continued listing status of the Common Stock on The Nasdaq Capital Market under the symbol "MOBX." If at any time during the additional 180-calendar-day extension, the bid price of the Common Stock closes at or above $1.00 per share for a minimum of ten consecutive business days, the Nasdaq staff will provide the Company with a written confirmation of compliance and the matter will be closed.

If the Company does not meet the minimum bid price requirement during the additional 180-calendar-day extension, Nasdaq will provide written notification to the Company that its Common Stock will be subject to delisting. At such time, the Company may appeal the delisting determination to a Nasdaq Hearings Panel (the "Panel"). The Common Stock would not remain listed pending the Panel's decision. There can be no assurance that if the Company does appeal a subsequent delisting determination to the Panel, that such appeal would be successful.

Mobix Labs remains committed to full compliance with all Nasdaq listing requirements and will continue to monitor its share price closely. The Company plans to take all necessary actions within the prescribed period to regain compliance.

For more information about Mobix Labs, please visit www.mobixlabs.com and connect with us on LinkedIn.

About Mobix Labs

Based in Irvine, California, Mobix Labs is a fabless semiconductor company delivering advanced wireless and wired connectivity, RF, switching, and filtering technologies for next-generation communication systems. Our solutions support aerospace, defense, 5G, medical, industrial, and other high-reliability markets. For more information, visit www.mobixlabs.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, without limitation, statements regarding the Company's expectations, intentions, strategies, beliefs, or projections concerning future events or the Company's future performance. These statements are often identified by words such as "anticipate," "believe," "could," "expect," "intend," "may," "plan," "project," "seek," "should," "target," "will," "would," or similar expressions. These statements are subject to numerous risks and uncertainties that could materially affect the Company's business, financial condition, and results of operations.

Forward-looking statements in this release include, but are not limited to, statements regarding the Company's plans to regain compliance with the Minimum Bid Price Requirement and the potential outcomes of such efforts. These statements are based on current assumptions, estimates, and expectations and are subject to known and unknown risks, uncertainties, and other factors—many of which are outside of the Company's control—that could cause actual results to differ materially from those expressed or implied by the forward-looking statements. Actual outcomes may differ materially from those expressed or implied, for example, due to changes in market conditions and the Company’s share price performance. There can be no assurance that the Company will regain compliance with the minimum bid-price requirement or otherwise meet Nasdaq compliance standards, that Nasdaq will grant the Company any relief from delisting as necessary or that the Company can ultimately meet applicable Nasdaq requirements for any such relief, fluctuations in the market price of the Company’s securities, potential changes in Nasdaq’s listing rules or their interpretation, the timing and outcome of any potential actions to regain compliance (including a reverse stock split, if necessary), competitive dynamics, regulatory developments, and risks described in the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the U.S. Securities and Exchange Commission ("SEC").

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contacts

Media Contact:
Chris Lancaster, Mobix Labs, Inc.
clancaster@mobixlabs.com

Investor Contact:
Ryan Battaglia, Mobix Labs, Inc.
rbattaglia@mobixlabs.com

FAQ

What did Nasdaq grant Mobix Labs (MOBX) on October 30, 2025?

Nasdaq granted a 180-calendar-day extension to regain compliance with the $1.00 minimum bid price requirement.

What is the new deadline for Mobix Labs (MOBX) to regain compliance?

The company now has until April 27, 2026 to meet the minimum bid price requirement.

Does the Nasdaq extension affect Mobix Labs' (MOBX) current listing status?

No, Nasdaq's extension has no immediate effect on the Common Stock's continued listing on Nasdaq Capital Market.

What happens if Mobix Labs (MOBX) does not meet the minimum bid price by April 27, 2026?

Nasdaq will issue a delisting notification; the company may appeal to a Nasdaq Hearings Panel but the shares would not remain listed pending that decision.

Has Mobix Labs (MOBX) previously met the $1.00 threshold during the compliance period?

Yes, the company maintained closing bid prices at or above $1.00 for ten consecutive trading days, achieving that on September 11, 2025.

Can Mobix Labs (MOBX) regain compliance before the extension ends?

Yes; if the bid price closes at or above $1.00 for a minimum of ten consecutive business days during the extension, Nasdaq will provide written confirmation of compliance.